GlassScriptPhysician profile
Richard W Ahn
NPI 1497098925
$1,069.52
in general payments reported to CMS, 2019-2025
16 companies · $233 in 2025
The $233 reported for 2025 was more than what a typical Diagnostic Radiology provider received nationally (typical 2025 total: $112).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $218 · 2020: $356 · 2021: $36.39 · 2022: $54.87 · 2023: $87.28 · 2024: $84.48 · 2025: $233.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $405.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $404.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sirtex Medical INC | $158.80 | 2019 | |
| Siemens Medical Solutions USA, INC. | $135.11 | 2020-2024 | Naeotom Alpha |
| Penumbra, INC. | $124.86 | 2020 | |
| Boston Scientific Corporation | $121.73 | 2020 | |
| Ucb, INC. | $94.58 | 2024-2025 | Rystiggo, Fintepla |
| Neurocrine Biosciences, INC. | $90.07 | 2025 | |
| Acorda Therapeutics, INC | $59.09 | 2019 | |
| Aprecia Pharmaceuticals, LLC | $46.99 | 2022-2023 | Spritam |
| Axsome Therapeutics, INC. | $39.95 | 2025 | Symbravo |
| Bard Peripheral Vascular, INC. | $39.44 | 2022 | |
| Adamas Pharmaceuticals, INC. | $37.86 | 2020 | |
| Kerecis Limited | $33.43 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Emd Serono, INC. | $28.93 | 2025 | |
| Sk Life Science, INC. | $22.83 | 2021 | |
| Abbvie INC. | $22.29 | 2023 | Ubrelvy, Qulipta |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $13.56 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Ahn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.